| Common Stock, Shares Authorized |
400,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
106,175,229 |
shares |
-0.63% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$72,800,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$185,400,000 |
USD |
0.92% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$30,200,000 |
USD |
-52% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$62,200,000 |
USD |
-7.2% |
Q4 2025 |
FY 2025 |
| Operating Lease, Liability |
$62,700,000 |
USD |
-13% |
Q4 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$206,900,000 |
USD |
167% |
Q4 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$77,000,000 |
USD |
-14% |
Q4 2025 |
FY 2025 |
| Property, Plant and Equipment, Gross |
$245,700,000 |
USD |
-20% |
Q4 2025 |
FY 2025 |
| Operating Lease, Liability, Current |
$9,700,000 |
USD |
-17% |
Q4 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$12,000,000 |
USD |
-1.6% |
Q4 2025 |
FY 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.059 |
pure |
0% |
Q4 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$2,400,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$14,300,000 |
USD |
-20% |
Q4 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$9,700,000 |
USD |
-14% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$20,500,000 |
USD |
-3.8% |
Q4 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$13,200,000 |
USD |
-18% |
Q4 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$8,500,000 |
USD |
-8.6% |
Q4 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$91,700,000 |
USD |
-3.7% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$32,000,000 |
USD |
765% |
Q4 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$14,600,000 |
USD |
-0.68% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$18,100,000 |
USD |
-17% |
Q4 2025 |
FY 2025 |